v3.26.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common stock
Additional paid-in capital
Accumulated deficit
Accumulated other comprehensive income
Balance (in shares) at Mar. 31, 2025   77,085,024      
Balance at Mar. 31, 2025 $ 415,843 $ 77 $ 1,358,897 $ (948,579) $ 5,448
Increase (decrease) in Stockholders' Equity          
Foreign currency translation adjustment (938)       (938)
Unrealized loss on short-term investments (269)       (269)
Exercise of stock options (in shares)   966      
Exercise of stock options 8   8    
Vesting of RSUs (in shares)   721,184      
Vesting of RSUs 2 $ 1 1    
Stock-based compensation expense 8,762   8,762    
Net loss (86,693)     (86,693)  
Balance (in shares) at Jun. 30, 2025   77,807,174      
Balance at Jun. 30, 2025 336,715 $ 78 1,367,668 (1,035,272) 4,241
Balance (in shares) at Mar. 31, 2026   82,716,923      
Balance at Mar. 31, 2026 166,160 $ 82 1,423,194 (1,262,519) 5,403
Increase (decrease) in Stockholders' Equity          
Foreign currency translation adjustment 582       582
Unrealized loss on short-term investments $ (9)       (9)
Exercise of stock options (in shares) 118,075 118,075      
Exercise of stock options $ 1,004 $ 1 1,003    
Vesting of RSUs (in shares)   1,144,368      
Vesting of RSUs 0 $ 1 (1)    
Stock-based compensation expense 7,674   7,674    
Net loss (69,766)     (69,766)  
Balance (in shares) at Jun. 30, 2026   83,979,366      
Balance at Jun. 30, 2026 $ 105,645 $ 84 $ 1,431,870 $ (1,332,285) $ 5,976